Colorectal cancer mortality can be reduced;Dödligheten i kolorektal cancer kan reduceras: Screening for blod i avföringen effektivt test

Lakartidningen

Volumn , Issue 25, 1998, Pages 2950-2952

  Kewenter, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; COLON POLYPOSIS; COLON TUMOR; COLORECTAL TUMOR; HUMAN; MASS SCREENING; METHODOLOGY; MORTALITY; OCCULT BLOOD; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR; REVIEW; SIGMOIDOSCOPE; SIGMOIDOSCOPY;

ADENOMATOUS POLYPOSIS COLI; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; MASS SCREENING; OCCULT BLOOD; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; SIGMOIDOSCOPES; SIGMOIDOSCOPY;

EID: 0032540577     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Greger DH. Diagnosis of large bowel cancer in the asymptomatic patient. JAMA 1967; 201: 943-5.
2. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
4. Kronborg O, Fenger C, Olsen J, Jörgensen OD, Söndergaard O. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996; 348: 1467.
5. Kewenter J, Brevinge H, Engarås B, Haglind E, Åhren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Scand J Gastroenterol 1994; 29: 468-73.
6. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A care-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-7.
7. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5.
8. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. Ann Intern Med 1995; 123: 904-10.
9. Nyström L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography : Overview of Swedish randomised trials. Lancet 1993; 341: 973-8.
10. Towler B, Irwing L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ, Under publ.
11. Hertz RE, Deddish MR, Day D. Value of periodic examinations in detecting cancer of the rectum and of the colon. Postgrad Med 1960; 27: 290-4.
12. Gilbertsen VA, Nelms JM. The prevention of invasive cancer of the rectum. Cancer 1978; 41: 1137-9.
13. Atkin WS, Morson BC, Cuzick J. Longterm risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658-62.
14. Cohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE. The prostate, lung, colorectal and ovarian cancer screening trial of the national cancer institute. Cancer Suppl 1995; 75: 1869-73.
15. Atkin WS, McIntyre P, Cuzick J, Edwards R, Northover JMA. Pilot study fo a multicentre randomised trial of Once only' flexible sigmoidoscopy (FS) for prevention of bowel cancer. Gut 1996; 38: A9.
16. Zarchy TM, Ershoff D. Do characteristic of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology 1994; 106: 1501-4.
17. Muleahy HE, Farthing MJG, O'Donoghue DP. Clinical Review. Screening for asymptomatic colorectal cancer. BMJ 1997; 314: 285-91.
18. Spigelman AD, Williams CB, Talbot IC, Domizio Phillips RKS. Upper gastointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2: 783-5.
19. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
20. Charatan FB. US recommends screening for colon cancer. BMJ 1997; 314: 396.